Radiotherapy and temozolomide for newly diagnosed glioblastoma: Recursive partitioning analysis of the EORTC 26981/22981-NCIC CE3 phase III randomized trial
René Olivier Mirimanoff*, Thierry Gorlia, Warren Mason, Martin J. Van Den Bent, Rolf Dieter Kortmann, Barbara Fisher, Michele Reni, Alba A. Brandes, Jüergen Curschmann, Salvador Villa, Gregory Cairncross, Anouk Allgeier, Denis Lacombe, Roger Stupp
Dive into the research topics of 'Radiotherapy and temozolomide for newly diagnosed glioblastoma: Recursive partitioning analysis of the EORTC 26981/22981-NCIC CE3 phase III randomized trial'. Together they form a unique fingerprint.